The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Mojisola Adeyeye, has reassured Nigerians that the agency remains a steadfast beacon of hope as it continues its relentless efforts to safeguard public health in Nigeria.
Adeyeye made this assertion at the 2023 NAFDAC Awards, Recognition, and retirement ceremony, held Wednesday in Lagos.
The event was also to honour the 42 staff members who were instrumental in securing the World Health Organization (WHO) Pre-Qualification for NAFDAC’s Central Drug Control Laboratory (CDCL) in Yaba were among the 138 employees honored for their exemplary service to the nnation.
She said the reflection on the dedication and perseverance of the staff acknowledged their unwavering commitment.
She stated: “Year after year, you have risen to the challenge. Your countless nights spent poring over reports, the rigorous field operations you have undertaken, and the complex decisions you have made contributed to saving lives, improving the quality of life, and building trust in our healthcare system.
“we recognise individuals who have not only upheld but elevated the standards of NAFDAC through their extraordinary contributions.
“Your efforts have touched millions of lives in ways that may never be fully quantified. Today, we honour not just your achievements, but the spirit of service that drives you,” Adeyeye stated.
NAFDAC boss noted that it was a celebration of the relentless dedication, hard work, and unyielding spirit that each staff member brings to NAFDAC every day.
She further stated the NAFDAC’s significant milestones over the past year, attributing these achievements to the collective effort and commitment of the workforce and among these milestones, she singled out the WHO Pre-Qualification of the Central Drug Control Laboratory as a crowning achievement.
She added that this milestone as not merely a feather in NAFDAC’s cap but a quantum leap in the agency’s mission to ensure the safety and efficacy of medicines available to the public.